Susquehanna Fundamental Investments, LLC Galapagos Nv Call Options Transaction History
Susquehanna Fundamental Investments, LLC
- $4.33 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GLPG
# of Institutions
91Shares Held
17.3MCall Options Held
10.4KPut Options Held
33.1K-
Eco R1 Capital, LLC San Francisco, CA5.76MShares$161 Million5.04% of portfolio
-
Bvf Inc San Francisco, CA1.57MShares$43.9 Million1.19% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$39.5 Million0.73% of portfolio
-
Prosight Management, LP Dallas, TX1.35MShares$37.8 Million10.45% of portfolio
-
Primecap Management CO Pasadena, CA720KShares$20.2 Million0.02% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.84B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...